Diebold Nixdorf (DBD) Tops Q1 EPS by 5c; offers guidance
Get Alerts DBD Hot Sheet
Price: $55.05 -6.92%
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q1 EPS of $0.67, $0.05 better than the analyst estimate of $0.62. Revenue for the quarter came in at $891.8 million, versus $0 reported last year.
GUIDANCE:
Diebold Nixdorf sees FY2026 EPS of $5.25-$5.75, versus the consensus of $5.49. Diebold Nixdorf sees FY2026 revenue of $3.86-3.94 billion, versus the consensus of $3.902 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Updates US Conviction List Directors' Cut
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
- Wysera Launches an AI Agent That Writes Marketing Content in a Company's Own Voice
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share